TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Debt | ₹3,026 Cr | ₹3,937 Cr | ₹5,297 Cr | ₹4,018 Cr | ₹4,825 Cr |
What is the latest Total Debt ratio of TORRENT PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2025 | ₹3,026 Cr |
Mar2024 | ₹3,937 Cr |
Mar2023 | ₹5,297 Cr |
Mar2022 | ₹4,018 Cr |
Mar2021 | ₹4,825 Cr |
How is Total Debt of TORRENT PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2025 | ₹3,026 Cr | -23.15 | |
Mar2024 | ₹3,937 Cr | -25.67 | |
Mar2023 | ₹5,297 Cr | 31.84 | |
Mar2022 | ₹4,018 Cr | -16.73 | |
Mar2021 | ₹4,825 Cr | - |
Compare Total Debt of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹119,526.3 Cr | -3% | -2.4% | 3.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,469.0 Cr | 0.5% | -2.3% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,672.0 Cr | 0.9% | -0.8% | 10.8% | Stock Analytics | |
CIPLA | ₹125,034.0 Cr | -0.3% | -0.9% | -3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,571.0 Cr | 0.6% | 3.9% | -0.4% | Stock Analytics | |
MANKIND PHARMA | ₹106,634.0 Cr | -0.2% | 4.8% | 6% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -3% |
-2.4% |
3.8% |
SENSEX | 1.2% |
1.9% |
-0.2% |
You may also like the below Video Courses